The health system and tech company came together in 2021 to use AI and quantum and other high-powered computing to discover new medical advances. The researchers, who published their work Jan. 16 in Briefings in Bioinformatics, developed AI to learn how immune systems recognize cancer cells, opening avenues for new immunotherapy treatments.
“These discoveries are an example of what makes this partnership successful — combining IBM’s cutting-edge computational resources with Cleveland Clinic’s medical expertise,” said Timothy Chan, MD, PhD, chair of Cleveland Clinic’s Center for Immunotherapy and Precision Immuno-Oncology, in a Jan. 23 news release. “These findings resulted from a key collaboration between everyone from a world-class expert in cancer immunotherapy to our physics-based simulation and AI experts. Collaboration when combined with innovation has terrific potential.”
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
